Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Approvals Analysis: Original PMA Slowdown, De Novo Upswing Among Recent Trends

Executive Summary

The volume of original PMAs coming to US FDA for review is down recently, while panel-track supplement, de novo and 510(k) volumes are up. October, meanwhile, was a relatively light month for novel device approvals, but better-than-average for 510(k) clearances.

Advertisement

Related Content

DEVICE DEBUTS: Product And New Indication Launches From Medtronic, Strkyer, Siemens, And More
'Refuse-To-Accept' Policy Outlined For De Novos In New US FDA Draft Guidance
US Approvals Analysis: 2016 Another Record Year For FDA Novel Device Approvals
Respicardia's remedē Neurostimulator Improves Sleep Apnea Symptoms In Pivotal Trial

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT121749

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel